a.cardoso
TL2 Moderator · Braga
Contributes reviews on supplier material. Based in Braga.
Joined 18 September 2025 · last posted 2d
84 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #132 · Meta › Feature requests · 26 Jul 2026 · 22 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #10 · Compounds › Repair & healing peptides · 25 Jul 2026 · 17 likes Picking up post #7: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #59 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 3 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Priming a pen and whether the primed volume is wasted Replied, post #15 · Devices › Pens & autoinjectors · 20 Jul 2026 · 13 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #28 · Access › Shortages · 19 Jul 2026 · 22 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #46 · Compounds › Secretagogues & GH axis · 17 Jul 2026 · 6 likes Coming back to post #44, because the follow-up matters more than the original answer. What a well-designed human trial of a secretagogue would look like: randomised,…
-
An 18-month record including the parts that went badly Replied, post #70 · Outcomes › Progress reports · 15 Jul 2026 · 0 likes This follows post #67 rather than contradicting it. Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss.…
-
Immortal time bias in a claims-database study — one year on Replied, post #17 · Evidence › Study critique · 11 Jul 2026 · 18 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #59 · Evidence › Journal club · 6 Jul 2026 · 23 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #96 · Sourcing › Vendor reports · 5 Jul 2026 · 0 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #26 · Pharmacology › Receptor biology · 24 Jun 2026 · 19 likes Picking up post #23: that is the part I would want checked first. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #67 · Start Here › How to Ask · 24 Jun 2026 · 1 like post #66 answers the question as asked. The question underneath it is different. Five questions in one post gets you one answer: the easiest one, usually not the one…
-
Follow-up: Sleep quality changes during weight loss Replied, post #37 · Wellbeing › Sleep · 4 Jun 2026 · 0 likes Worth separating two things that post #33 runs together. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months,…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #124 · Compounds › Tirzepatide · 14 May 2026 · 3 likes On post #120 — agreed on the reasoning, with one qualification. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #53 · Practice › Reconstitution · 14 May 2026 · 13 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #20 · Analytics › Home & field testing · 12 May 2026 · 4 likes post #19 answers the question as asked. The question underneath it is different. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain…
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #8 · Analytics › HPLC & UHPLC · 7 May 2026 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Method validation is the demonstration that a method can separate the compound from…
-
Journal club: is percentage weight change the right endpoint? Replied, post #101 · Evidence › Journal club · 25 Apr 2026 · 0 likes post #100 answers the question as asked. The question underneath it is different. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the…
-
Five questions in one post gets you one answer — how to split them Replied, post #62 · Start Here › How to Ask · 23 Apr 2026 · 4 likes Worth separating two things that post #58 runs together. Lab result questions: state the result, the reference interval, and what else is on the same panel. A single…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #89 · Compounds › Tirzepatide · 19 Apr 2026 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #85 · Analytics › Mass spectrometry · 15 Apr 2026 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #33 · Sourcing › Logistics · 4 Apr 2026 · 23 likes post #32 answers the question as asked. The question underneath it is different. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there…
-
Transporting a vial for a weekend away — a second dataset Replied, post #10 · Practice › Storage & stability · 19 Mar 2026 · 15 likes post #9 is right about the mechanism and I think understates the practical bit. Beyond-use dating: the date after which a prepared solution should not be used. It is an…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #76 · Compounds › Semaglutide · 9 Mar 2026 · 9 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #51 · Analytics › Impurities & related substances · 26 Feb 2026 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #80 · Clinical › Bloodwork · 19 Feb 2026 · 8 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #46 · Clinical › Special populations · 18 Feb 2026 · 2 likes On post #42 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Second pass at: Identical chromatograms across two different lots Replied, post #8 · Sourcing › Red flags · 14 Feb 2026 · 18 likes I read post #6 twice before replying, because I had assumed the opposite. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes…
-
Amylin receptor signalling and satiety — what changed since Replied, post #25 · Pharmacology › Receptor biology · 3 Feb 2026 · 3 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #91 · Clinical › Special populations · 3 Feb 2026 · 31 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #96 · Clinical › Special populations · 26 Jan 2026 · 3 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #10 · Pharmacology › Pharmacokinetics · 7 Jan 2026 · 29 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #5 · Practice › Administration · 1 Jan 2026 · 3 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Coverage in the US: a map of the usual obstacles Replied, post #26 · Regional › North America · 23 Dec 2025 · 0 likes Picking up post #23: that is the part I would want checked first. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
-
DXA precision and the least significant change for lean mass Replied, post #49 · Outcomes › Body composition · 7 Dec 2025 · 3 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #58 · Practice › Interactions · 28 Nov 2025 · 5 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #15 · Compounds › Other compounds · 22 Nov 2025 · 7 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #3 · Safety › Contraindications · 10 Nov 2025 · 1 like On the opening post — agreed on the reasoning, with one qualification. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or…
-
Follow-up: Why appetite effects are mostly central Replied, post #85 · Pharmacology › Receptor biology · 3 Nov 2025 · 1 like Picking up post #82: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #25 · Devices › Pens & autoinjectors · 27 Oct 2025 · 0 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #23 · Start Here › How to Ask · 24 Oct 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #60 · Compounds › Semaglutide · 18 Sep 2025 · 14 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #136 · Practice › Storage & stability · 9 Sep 2025 · 8 likes Picking up post #133: that is the part I would want checked first. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #51 · Practice › Reconstitution · 3 Sep 2025 · 13 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
A request that was declined, and the reasoning — a second dataset Replied, post #61 · Documentation › Wiki requests · 12 Aug 2025 · 0 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Pricing far outside the range, in either direction Replied, post #2 · Sourcing › Red flags · 4 Aug 2025 · 5 likes Worth separating two things that the opening post runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #23 · Compounds › Oral incretins · 4 Aug 2025 · 15 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #13 · Analytics › Method validation · 12 Jul 2025 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #89 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 10 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #56 · Access › Insurance & coverage · 10 Jun 2025 · 13 likes Picking up post #53: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
GIP receptor agonism and the argument about direction Started this topic · Pharmacology › Receptor biology · 7 Jun 2025 · 40 likes GIP receptor agonism and the argument about direction — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #19 · Clinical › Bloodwork · 28 May 2025 · 15 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Counter-ion content and its effect on measured mass Replied, post #44 · Analytics › Mass spectrometry · 21 May 2025 · 2 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
A report I filed that turned out to be wrong, and the correction Replied, post #60 · Sourcing › Vendor reports · 19 May 2025 · 3 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #2 · marked as the solution · Evidence › Journal club · 10 May 2025 · 25 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Water content on a certificate and why it changes the arithmetic Replied, post #15 · Analytics › COA interpretation · 7 May 2025 · 23 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #105 · Evidence › Journal club · 22 Apr 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #8 · Clinical › Bloodwork · 18 Apr 2025 · 1 like I read post #6 twice before replying, because I had assumed the opposite. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #94 · Compounds › Cagrilintide & amylin analogues · 7 Apr 2025 · 2 likes Worth separating two things that post #90 runs together. What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #75 · Devices › Cold chain · 28 Mar 2025 · 0 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #53 · Sourcing › Vendor reports · 16 Mar 2025 · 32 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Retatrutide dose escalation in the published trials Replied, post #14 · Compounds › Retatrutide · 14 Mar 2025 · 7 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Ipamorelin selectivity claims and where they came from Replied, post #20 · Compounds › Secretagogues & GH axis · 14 Mar 2025 · 19 likes Coming back to post #18, because the follow-up matters more than the original answer. GHRH analogues versus ghrelin mimetics are often conflated but they are different…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #50 · Practice › Reconstitution · 9 Mar 2025 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
When "no data" is the complete and final answer Replied, post #106 · Compounds › Other compounds · 1 Mar 2025 · 16 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Reading an MS report that only gives you a single number Replied, post #8 · Analytics › Mass spectrometry · 10 Feb 2025 · 0 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
A promotion I argued against, and why I lost Replied, post #66 · Documentation › Doc review · 18 Jan 2025 · 1 like I read post #64 twice before replying, because I had assumed the opposite. New maintainer recruitment: if a page's maintainer is inactive and updates are needed,…
-
Oxidation pathways for methionine and tryptophan Replied, post #41 · Analytics › Impurities & related substances · 29 Dec 2024 · 12 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Reading a supplementary appendix and finding the interesting part Replied, post #52 · Evidence › Trials · 26 Dec 2024 · 1 like The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #22 · Compounds › Semaglutide · 20 Dec 2024 · 10 likes Coming back to post #20, because the follow-up matters more than the original answer. On alcohol: the labelling does not contraindicate it, but it raises gastric…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #44 · Access › Insurance & coverage · 27 Nov 2024 · 8 likes post #43 answers the question as asked. The question underneath it is different. Formulary status: the list of covered medications and the tier (how much you pay) they…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #39 · Clinical › Special populations · 22 Nov 2024 · 23 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #14 · Start Here › Welcome · 22 Nov 2024 · 10 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #85 · Clinical › Prescriber conversations · 25 Oct 2024 · 1 like Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #68 · Compounds › Other compounds · 23 Oct 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #20 · Clinical › Comorbidities · 11 Oct 2024 · 22 likes This follows post #17 rather than contradicting it. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent…
-
Requesting a page: what makes a good request — what changed since Replied, post #26 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Translation suggestions: if a maintained page should exist in another language,…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #12 · Practice › Administration · 6 Sep 2024 · 2 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Second pass at: Reimbursement variation across member states Replied, post #3 · Regional › European Union · 23 Aug 2024 · 5 likes post #2 is right about the mechanism and I think understates the practical bit. France: ANSM implements EU framework. Reimbursement has been narrower for weight…
-
Guidelines revision: what changed and why Replied, post #24 · Meta › Announcements · 25 Jul 2024 · 0 likes This follows post #21 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Circumference measurements as a poor man's composition estimate Replied, post #17 · Outcomes › Body composition · 24 Jul 2024 · 21 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #76 · Practice › Dosing & titration · 9 Jul 2024 · 11 likes post #75 answers the question as asked. The question underneath it is different. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Journal club: FLOW and the renal composite, component by component Started this topic · Evidence › Journal club · 7 Jul 2024 · 0 likes On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet ,…
-
The mass-error checker and its intended scope Replied, post #76 · Data & Tools › Calculators · 26 Jun 2024 · 6 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…